Health

Results: 5353-5364 of 8203

Exscientia Acquires Full Rights to Potential Best-in-Class CDK7 Inhibitor Ahead of Phase 1 Dose Escalation Data Readout

BeiGene Announces Appointment of Aaron Rosenberg as Chief Financial Officer

PR Newswire associated0

Windrose Consulting Group Announces the appointment of Jose Galan as a Partner, to continue its growth as a leader in Global Pricing & Market Access Strategy Services

PR Newswire associated0

Brainomix and Boehringer Ingelheim Launch Strategic Partnership in Fibrosing Lung Disease

Diamyd Medical receives second U.S. FDA Fast Track designation for Diamyd® - for the prevention of Type 1 Diabetes

Implantica launches RefluxStop™ advanced education program in Spain

Enzymatica's Board of Directors updates the financial targets

NEJM publishes ALTUVOCT® phase 3 XTEND-Kids results highlighting treatment potential for children with severe haemophilia A

Enzymatica's Board of Directors decides on a new rights issue of approximately SEK 130 million

Hansa Biopharma Reports Second Quarter 2024 Financial Results and Business Update

PR Newswire associated0

China's Medical Device Market Value Hits $179B, 90th CMEF in Shenzhen to Feature a Plethora of Technological Products

PR Newswire associated0

Jazz Pharmaceuticals to Report 2024 Second Quarter Financial Results on July 31, 2024